Clinical Trial Update: Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety after conversion to RaparoBell or My-Rept in kidney transplant patients. The study is currently active but not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• MY-REPT
• RaparoBell

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Kidney Transplantation | Phase 4 | Status: ACTIVE_NOT_RECRUITING